Skip to search formSkip to main contentSkip to account menu

NKP-1339

Known as: Ruthenium-based Transferrin Targeting Agent NKP-1339 
A ruthenium-containing cancer agent targeting transferrin with potential antineoplastic activity. Upon intravenous administration, NKP-1339 (Ru3… 
National Institutes of Health

Search for papers about NKP-1339

Search papers